JP2006504645A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006504645A5 JP2006504645A5 JP2004519701A JP2004519701A JP2006504645A5 JP 2006504645 A5 JP2006504645 A5 JP 2006504645A5 JP 2004519701 A JP2004519701 A JP 2004519701A JP 2004519701 A JP2004519701 A JP 2004519701A JP 2006504645 A5 JP2006504645 A5 JP 2006504645A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- hcv
- antibody
- protein
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/188,608 US20030180284A1 (en) | 1998-11-05 | 2002-07-02 | Prevention and treatment of HCV infection employing antibodies directed against conformational and linear epitopes |
| PCT/US2003/020580 WO2004005316A2 (en) | 2002-07-02 | 2003-06-27 | Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006504645A JP2006504645A (ja) | 2006-02-09 |
| JP2006504645A5 true JP2006504645A5 (enExample) | 2006-08-17 |
Family
ID=30114012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004519701A Pending JP2006504645A (ja) | 2002-07-02 | 2003-06-27 | 立体構造及び直鎖状エピトープに対する抗体を用いたhcv感染の予防及び治療 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20030180284A1 (enExample) |
| EP (1) | EP1572721A4 (enExample) |
| JP (1) | JP2006504645A (enExample) |
| AU (1) | AU2003247841A1 (enExample) |
| WO (1) | WO2004005316A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060188511A1 (en) * | 1998-11-05 | 2006-08-24 | Foung Steven K | Prevention and treatment of HCV infection employing antibodies directed against conformational and linear epitopes |
| ATE425187T1 (de) * | 2001-01-12 | 2009-03-15 | Molecules Of Man Ab | Materialien und methoden zur behandlung von hepatitis c |
| FR2843115B1 (fr) * | 2002-08-02 | 2007-11-09 | Commissariat Energie Atomique | Melange de peptides issus des proteines c et ns3 du virus de l'hepatite c et leurs applications |
| WO2006097682A1 (en) * | 2005-03-18 | 2006-09-21 | Ucl Business Plc | Mechano growth factor peptides and their use |
| EP2004685A4 (en) * | 2006-03-22 | 2009-04-29 | Genimmune N V | HEPATITIS C VIRUS NEUTRALIZING ANTIBODIES |
| RS53258B (sr) * | 2007-02-21 | 2014-08-29 | University Of Massachusetts | Humana antitela protiv virusa hepatitisa c (hcv) i njihove upotrebe |
| CN101809033A (zh) | 2007-07-25 | 2010-08-18 | 日本国立感染症研究所 | 对丙型肝炎病毒(hcv)感染具有抑制活性的抗体和其用途 |
| WO2010047829A1 (en) * | 2008-10-24 | 2010-04-29 | The Scripps Research Institute | Mutant hepatitis c virus e2 polypeptides for hcv treatment |
| CN102596996B (zh) | 2009-10-30 | 2014-06-18 | 东丽株式会社 | 对丙型肝炎病毒(hcv)具有感染抑制活性的抗体及其用途 |
| BR112016021576A2 (pt) * | 2014-03-20 | 2017-10-10 | Japan As Represented By Director General Of Nat Institute Of Infectious Diseases | ?anticorpo da proteína e2 de vírus anti-hepatite c ou fragmento do anticorpo que se liga ao antígeno da mesma, ácido nucleico, e, medicamento? |
| CN106749645B (zh) * | 2016-11-14 | 2019-12-03 | 广州泰诺迪生物科技有限公司 | 一种全人源抗丙型肝炎病毒的中和抗体 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ243558A (en) * | 1991-07-15 | 1994-06-27 | Wellcome Found | Recombinant primate antibodies and their production |
| DK0608261T3 (da) * | 1991-09-13 | 2003-03-17 | Chiron Corp | Sammensætninger med immunreaktivt hepatitis C virus polypeptid |
| EP1845108A3 (en) * | 1994-07-29 | 2007-10-24 | Innogenetics N.V. | Monoclonal antibodies to purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| IL118626A0 (en) * | 1996-06-11 | 1996-10-16 | Xtl Biopharmaceuticals Limited | Anti HBV antibody |
| EP0947525A1 (en) * | 1998-03-27 | 1999-10-06 | Innogenetics N.V. | Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue |
| AU2001292667A1 (en) * | 2000-09-13 | 2002-03-26 | Hawaii Biotechnology Group, Inc. | Immunogenic composition of hepatitis c and methods of use thereof |
-
2002
- 2002-07-02 US US10/188,608 patent/US20030180284A1/en not_active Abandoned
-
2003
- 2003-06-27 EP EP03763059A patent/EP1572721A4/en not_active Withdrawn
- 2003-06-27 WO PCT/US2003/020580 patent/WO2004005316A2/en not_active Ceased
- 2003-06-27 AU AU2003247841A patent/AU2003247841A1/en not_active Abandoned
- 2003-06-27 JP JP2004519701A patent/JP2006504645A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7507408B2 (en) | Anti hepatitis C virus antibody and uses thereof | |
| JP3477198B2 (ja) | C型肝炎ウィルス(hcv)に対する抗体の検出のためのペプチド及びその混合物 | |
| JP7536059B2 (ja) | チクングニヤウイルスの抗体媒介性中和 | |
| JP3645904B2 (ja) | C型肝炎ウイルスの型の分類方法およびそこで使用する試薬 | |
| JPH01500432A (ja) | Aidsおよびarcのウィルス原因物質に対して免疫化するための組成物および方法 | |
| JP2010501594A5 (enExample) | ||
| JP2004515202A5 (enExample) | ||
| JPH07503614A (ja) | Hcv蛋白のための哺乳動物発現システム | |
| JPH04253998A (ja) | C型肝炎アッセイ | |
| JP2012504602A5 (enExample) | ||
| JP2005531286A (ja) | HCVE2グリコプロテインに対して向けられ、invitro中和活性を有するヒトモノクローナル抗体Fab断片 | |
| Garcia et al. | Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells | |
| JP2004533991A5 (enExample) | ||
| JP2000514643A (ja) | B型肝炎表面抗原のa―決定基の抗原エピトープ及びその利用法 | |
| JPWO2007145192A1 (ja) | Iv型コラーゲン様免疫活性ペプチド | |
| Mattioli et al. | Mimicry of the immunodominant conformation-dependent antigenic site of hepatitis A virus by motifs selected from synthetic peptide libraries | |
| JPH0940694A (ja) | 肝炎gbウイルスの合成ペプチド及びその使用 | |
| CN100588660C (zh) | Sars冠状病毒核衣壳蛋白的抗原决定簇及其应用 | |
| Zhang et al. | A mimotope of pre-S2 region of surface antigen of viral hepatitis B screened by phage display | |
| El-Awady et al. | Conserved peptides within the E2 region of Hepatitis C virus induce humoral and cellular responses in goats | |
| Polimeno et al. | Sub-epitopic dissection of HCV E1315–328HRMAWDMMMNWSPT sequence by similarity analysis | |
| WO2005018538A2 (en) | Severe acute respiratory syndrome (sars) polypeptides, antibodies to sars polypeptides and the use thereof in diagnostic, vaccination and therapeutic applications | |
| JPS58150518A (ja) | B型肝炎ウイルスのための免疫学的組成物及び方法 | |
| JPH04159298A (ja) | Hcvペプチド | |
| CN100467484C (zh) | Sars早期诊断方法及试剂盒 |